These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2728003)

  • 1. Comparative toxicity of allylamine and acrolein in cultured myocytes and fibroblasts from neonatal rat heart.
    Toraason M; Luken ME; Breitenstein M; Krueger JA; Biagini RE
    Toxicology; 1989 May; 56(1):107-17. PubMed ID: 2728003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allylamine-induced vascular toxicity in vitro: prevention by semicarbazide-sensitive amine oxidase inhibitors.
    Ramos K; Grossman SL; Cox LR
    Toxicol Appl Pharmacol; 1988 Aug; 95(1):61-71. PubMed ID: 2842890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of rat heart mitochondrial electron transport in vitro: implications for the cardiotoxic action of allylamine or its primary metabolite, acrolein.
    Biagini RE; Toraason MA; Lynch DW; Winston GW
    Toxicology; 1990 May; 62(1):95-106. PubMed ID: 2343460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allylamine cardiotoxicity--IV. Metabolism to acrolein by cardiovascular tissues.
    Nelson TJ; Boor PJ
    Biochem Pharmacol; 1982 Feb; 31(4):509-14. PubMed ID: 7066019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of serum and cellular semicarbazide-sensitive amine oxidase to amine metabolism and cardiovascular toxicity.
    Conklin DJ; Langford SD; Boor PJ
    Toxicol Sci; 1998 Dec; 46(2):386-92. PubMed ID: 10048142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of glutathione S-transferases as a defense against reactive electrophiles in the blood vessel wall.
    He NG; Awasthi S; Singhal SS; Trent MB; Boor PJ
    Toxicol Appl Pharmacol; 1998 Sep; 152(1):83-9. PubMed ID: 9772203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allylamine and acrolein toxicity in perfused rat hearts.
    Sklar JL; Anderson PG; Boor PJ
    Toxicol Appl Pharmacol; 1991 Mar; 107(3):535-44. PubMed ID: 2000639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allylamine toxicity in embryonic myocardial myocyte reaggregate cultures.
    Kesingland K; Earl LK; Roberts JC; Jones HB
    Toxicol In Vitro; 1991; 5(2):145-56. PubMed ID: 20732009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of plasma semicarbazide-sensitive amine oxidase in allylamine and beta-aminopropionitrile cardiovascular toxicity: mechanisms of myocardial protection and aortic medial injury in rats.
    Conklin DJ; Trent MB; Boor PJ
    Toxicology; 1999 Nov; 138(3):137-54. PubMed ID: 10593505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allylamine cardiotoxicity: III. Protection by semicarbazide and in vivo derangements of monoamine oxidase.
    Boor PJ; Nelson TJ
    Toxicology; 1980; 18(2):87-102. PubMed ID: 7256782
    [No Abstract]   [Full Text] [Related]  

  • 11. Semicarbazide protection from in vivo oxidant injury of vascular tissue by allylamine.
    Awasthi S; Boor PJ
    Toxicol Lett; 1993 Feb; 66(2):157-63. PubMed ID: 8430435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amine metabolism: a novel path to coronary artery vasospasm.
    Conklin DJ; Boyce CL; Trent MB; Boor PJ
    Toxicol Appl Pharmacol; 2001 Sep; 175(2):149-59. PubMed ID: 11543647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of benzylamine oxidase in the cytotoxicity of allylamine toward aortic smooth muscle cells.
    Hysmith RM; Boor PJ
    Toxicology; 1988 Oct; 51(2-3):133-45. PubMed ID: 3140421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acrolein generation stimulates hypercontraction in isolated human blood vessels.
    Conklin DJ; Bhatnagar A; Cowley HR; Johnson GH; Wiechmann RJ; Sayre LM; Trent MB; Boor PJ
    Toxicol Appl Pharmacol; 2006 Dec; 217(3):277-88. PubMed ID: 17095030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of glutathione S-transferase 8-8 in allylamine resistance of vascular smooth muscle cells in vitro.
    He N; Singhal SS; Awasthi S; Zhao T; Boor PJ
    Toxicol Appl Pharmacol; 1999 Jul; 158(2):177-85. PubMed ID: 10406932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrastructural alterations in allylamine cardiovascular toxicity. Late myocardial and vascular lesions.
    Boor PJ; Ferrans VJ
    Am J Pathol; 1985 Oct; 121(1):39-54. PubMed ID: 4050976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of activity of semicarbazide-sensitive aminooxidases and cellular glutathione on the cytotoxic effect of allylamine, acrolein, and formaldehyde in human cultured endothelial cells].
    Pino R; Lyles GA
    Vopr Med Khim; 1997; 43(6):537-47. PubMed ID: 9503571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allylamine toxicity in embryonic myocardial myocyte reaggregate cultures: The role of extracellular metabolism by benzylamine oxidase.
    Earl LK; Kesingland K; Davis KP; Brocklehurst SR; Jones HB
    Toxicol In Vitro; 1992 Sep; 6(5):405-16. PubMed ID: 20732139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative cytotoxic responses of cultured avian and rodent aortic smooth muscle cells to allylamine.
    Ramos KS; Thurlow CH
    J Toxicol Environ Health; 1993 Sep; 40(1):61-76. PubMed ID: 8360943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of the neonatal rat cardiomyocyte in culture to energy depletion: effects of cytokines, nitric oxide, and heat shock proteins.
    Wang D; McMillin JB; Bick R; Buja LM
    Lab Invest; 1996 Dec; 75(6):809-18. PubMed ID: 8973476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.